Subscribe To

Price Alert Latest News Economic Calendar News

SZLSF / StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting

TORONTO, ON / ACCESSWIRE / June 28, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company") is pleased to report that shareholders voted in favour of all of the tabled resolutions listed in the Company's management information circular dated May 12, 2022 (the "Circular"), at its annual and special meeting of shareholders held on June 28, 2022 (the "Meeting"). The results of the vote for the election of directors are as follows: For Withheld James Howard-Tripp 84% 16% Rory Riggs 89% 11% Harry Glorikian 89% 11% Garth MacRae 89% 11% Shareholders also voted in favour of the following matters: Appointment of SRCO Professional Services LLP as auditors of the Company with 97% votes for; and Stock Option Plan renewal - 77% votes for. Read More

Demo Live Account See Partner Details

Content Topics

Stagezero

Life

Sciences

Announces

Results

Resolutions

Annual

Special

Meeting

Stock

SZLSF

Posted: Jun 28 2022, 17:20

Author Name: Accesswire

SZLSF News

By Newsfile Corp
June 5, 2023

StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - StageZero Life Sciences, Ltd. (TSX: SZLS) ("StageZero" or the "Company") today announced that it w

By Newsfile Corp
March 29, 2023

StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30

Toronto, Ontario--(Newsfile Corp. - March 29, 2023) - StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will

By Accesswire
June 28, 2022

StageZero Life Sciences Announces Results on Resolutions at Annual and Special Meeting

TORONTO, ON / ACCESSWIRE / June 28, 2022 / StageZero Life Sciences, Ltd (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company") is pleased to report th

By Seeking Alpha
May 17, 2022

StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q1 2022 Results - Earnings Call Transcript

StageZero Life Sciences Ltd. (OTCPK:SZLSF) Q1 2022 Earnings Conference Call May 17, 2022 8:30 AM ET Company Participants Rebecca Greco - Head of Inves

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.